TYPBAR is a sterile solution containing the cell surface Vi polysaccharide extracted from Salmonella typhi Ty2 strain. TYPBAR is indicated for active immunization against typhoid fever for both adults and children two years of age or older. Selective immunization with TYPBAR is recommended for travellers to high endemic areas, household contacts of carriers, healthcare personnel, Police, Armed forces etc.
The immunizing dose for adults and children 2 years of age and older is a single dose of 0.5 mL. Subjects who remain at risk of typhoid fever should be given a single booster dose of the vaccine with an interval of not more than 3 years.
For latest IAP updates see revised immunization schedule.
TYPBAR should not be administered to subjects with known hypersensitivity to any component of the vaccine or to subjects having shown signs of hypersensitivity after a previous administration.